Avid Presentations for the January 20, 2011 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee

January 20, 2011 A January 18, 2011 U.S. Food and Drug Administration (FDA) advisory committee meeting discussed recommending approving the use of brain scans and the imaging compound, Amyvid, to help rule out Alzheimer’s disease as a cause of cognitive decline. U.S. Food and Drug Administration (FDA). Download the Report . . .